EMA Authorised: Vizarsin (sildenafil) — Krka, d.d., Novo mesto

View source ↗

Summary

The EMA authorised Vizarsin (sildenafil) for erectile dysfunction under Krka, d.d., Novo mesto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Vizarsin (sildenafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Krka, d.d., Novo mesto. Decision date: 22/02/2023